pamidronate has been researched along with Burns in 5 studies
Burns: Injuries to tissues caused by contact with heat, steam, chemicals (BURNS, CHEMICAL), electricity (BURNS, ELECTRIC), or the like.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schryver, E | 1 |
| Klein, GL | 5 |
| Herndon, DN | 5 |
| Suman, OE | 2 |
| Branski, LK | 1 |
| Sousse, LE | 1 |
| Børsheim, E | 1 |
| Hawkins, HK | 1 |
| Cotter, M | 1 |
| Le, PT | 1 |
| Andersen, CR | 1 |
| Benjamin, D | 1 |
| Rosen, CJ | 1 |
| Wimalawansa, SJ | 1 |
| Kulkarni, G | 1 |
| Sherrard, DJ | 2 |
| Sanford, AP | 1 |
| Przkora, R | 1 |
| Chinkes, DL | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Zoledronic Acid for Prevention of Bone Loss After BAriatric Surgery (ZABAS)[NCT04742010] | Phase 2 | 60 participants (Anticipated) | Interventional | 2021-02-20 | Recruiting | ||
| Prevention of Bone Loss After Pediatric Hematopoietic Cell Transplantation[NCT02074631] | Phase 2 | 80 participants (Actual) | Interventional | 2015-02-28 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for pamidronate and Burns
| Article | Year |
|---|---|
Bone metabolism in pediatric burned patients: A review.
Topics: Adaptor Proteins, Signal Transducing; Aluminum; Body Composition; Bone and Bones; Bone Density; Bone | 2018 |
4 trials available for pamidronate and Burns
| Article | Year |
|---|---|
Pamidronate attenuates muscle loss after pediatric burn injury.
Topics: Adolescent; Biopsy; Burns; Child; Diphosphonates; Humans; Muscle Proteins; Muscles; Pamidronate; Phe | 2014 |
The effect of burn on serum concentrations of sclerostin and FGF23.
Topics: Adaptor Proteins, Signal Transducing; Adolescent; Analysis of Variance; Anti-Inflammatory Agents; Bo | 2015 |
The efficacy of acute administration of pamidronate on the conservation of bone mass following severe burn injury in children: a double-blind, randomized, controlled study.
Topics: Absorptiometry, Photon; Acute Disease; Adolescent; Amino Acids; Anti-Inflammatory Agents; Biomarkers | 2005 |
Pamidronate preserves bone mass for at least 2 years following acute administration for pediatric burn injury.
Topics: Bone Density; Bone Density Conservation Agents; Burns; Child; Diphosphonates; Humans; Lumbar Vertebr | 2007 |